In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally effective ...

Older people with diabetes are at greater risk of heart failure and strokes. SGLT2 inhibitors, which include the daily ...

SGLT-2 inhibitors canagliflozin, empagliflozin, and dapagliflozin showed overall comparable effectiveness on cardiovascular outcomes in T2D.

SGLT2 inhibitors help lower blood sugar by causing the kidneys to eliminate more sugar in the urine.Farxiga is used alongside ...

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes.

Calorie restriction, physical activity and the drug dapagliflozin caused 44% of participants in a small trial to enter diabetes remission Dapagliflozin is a sodium glucose co-transporter 2 (SGLT2) ...

Akums combines two potent diabetes medicines for enhanced treatment efficacy: Our Bureau, Bengaluru Tuesday, February 4, 2025, 15:30 Hrs [IST] Akums Drugs and Pharmaceuticals, a l ...

Only the 5-mg dose of dapagliflozin, not recommended for cardiovascular risk reduction, showed a reduced benefit. Individual SGLT2 inhibitors showed roughly comparable cardiovascular effectiveness ...

For this study, researchers focused on the SGLT-2 drug dapagliflozin, and how it worked in combination with a calorie-restricted diet. “SGLT-2 inhibits are a class of medications that inhibit ...

Combined strategy is effective but questions remain The view that the hyperglycaemia associated with type 2 diabetes is ...

In keeping with current guidelines, either empagliflozin or dapagliflozin can be used for preventing AKI and CKD in patients with type 2 diabetes. Empagliflozin and dapagliflozin are equally ...

Dapagliflozin plus calorie restriction beneficial for patients with overweight or obesity and type 2 diabetes. (HealthDay News) — For patients with overweight or obesity and type 2 diabetes ...